NCT00114244View on ClinicalTrials.gov

Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Stage IV Pancreatic Cancer
Interventions
DRUG

sorafenib tosylate

Given PO

DRUG

gemcitabine hydrochloride

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

91010

City of Hope, Duarte

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00114244 - Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter